Is adjuvant immunotherapy a new standard for non‐pathological complete response patients with resectable esophageal squamous cell carcinoma?

Detalles Bibliográficos
Autores principales: Wang, Jun, Hui, Zhouguang, Pang, Qingsong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley & Sons Australia, Ltd 2022
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626336/
https://www.ncbi.nlm.nih.gov/pubmed/36214057
http://dx.doi.org/10.1111/1759-7714.14641

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9626336/
https://www.ncbi.nlm.nih.gov/pubmed/36214057
http://dx.doi.org/10.1111/1759-7714.14641

Ejemplares similares